Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy [Phase 3]
This document provides an update on a Phase 3 clinical trial evaluating AK112 as consolidation therapy for patients with limited-stage small…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
A clinical trial update describes a PD-L1–targeting peptide probe for PET imaging of solid tumors, with not-yet-recruiting status and condit…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Talazoparib and Thoracic RT for ES-SCLC [Phase 1]
Phase 1 clinical trial evaluating talazoparib in combination with thoracic radiotherapy for extensive-stage small cell lung cancer is curren…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis [Phase 2]
A Phase 2 study is evaluating stereotactic radiosurgery for brain metastases from small cell lung cancer. The trial is currently active but …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of FZ-AD005 in Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 study evaluating FZ-AD005 in adults with advanced solid tumors, including small cell lung cancer and large cell neuroendoc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating ZG006 in combination with PD-1/PD-L1 inhibitors as first-line therapy for extensive-stage small cell lung cancer.…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES) [Phase 2]
This entry describes a Phase 2 trial investigating durvalumab with ablative radiation for small-cell lung cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Concurrent or Sequential Immunotherapy and Radiation Therapy in Patients With Metastatic Lung Cancer [Phase 1]
This clinical trial update discusses a Phase 1 study of concurrent or sequential immunotherapy and radiation therapy in patients with metast…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC [Phase 2]
A Phase 2, open-label, randomized, multicenter study evaluating different dosing regimens of tarlatamab in patients with small cell lung can…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: First in Human Study of TUB-030 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
First-in-human study of TUB-030 is underway in patients with advanced solid tumors, including head and neck squamous cell carcinoma, small c…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Study of Oral MRT-2359 in Selected Cancer Patients [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 trial evaluating MRT-2359 in multiple cancer indications; trial is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Engagement of Veterans With Lung Cancer [NA]
A clinical trial update indicates the study sponsored by Palo Alto Veterans Institute for Research is currently recruiting veterans with var…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing Ifinatamab Deruxtecan to physician's choice in relapsed small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients. [Phase 3]
Phase 3 clinical trial evaluating adding anlotinib to whole-brain radiotherapy in small cell lung cancer patients with brain metastases; cur…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC [Phase 2]
A Phase 2 clinical trial evaluating golidocitinib in combination with PD-1 inhibitors as maintenance therapy for previously untreated extens…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC
A real-world study evaluating the efficacy and safety of Adebrelimab in patients with advanced Small Cell Lung Cancer. Recruitment is ongoin…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating the safety and tolerability of TransCon IL-2 β/γ alone or in combination w…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating MK-6070 (HPN328-4001), a DLL3-targeted therapy, in advanced cancers expressing DLL3, including small c…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: A French Real-life Study: EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer.
A real-world French study evaluating how durvalumab is used and its effectiveness as first-line therapy for extensive-stage small cell lung …
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI Treatment [Phase 2]
Phase 2 trial evaluating safety and efficacy of Tarlatamab with etoposide, carboplatin, and atezolizumab in transformed small cell lung canc…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors [EARLY_Phase 1]
Early-phase clinical trial investigating a radiolabeled anti-PD-L1 single-domain antibody (177Lu-anti-PD-L1 sdAb) in metastatic solid tumors…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Tasca Therapeutics is testing CP-383 in a Phase 1/2 trial for patients with advanced or metastatic solid tumors, including colorectal cancer…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC [Phase 1]
A Phase I study to evaluate the safety, tolerability, and pharmacokinetics of HLX3901 in patients with advanced small cell lung cancer or ne…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer [Phase 2]
This entry describes a Phase 2 clinical trial evaluating adjuvant chemotherapy and immunotherapy after complete surgical resection in small …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]
A Phase 2 study evaluating alisertib in extensive-stage small cell lung cancer is currently recruiting. The sponsor is Puma Biotechnology.